Lok-Beta Pharmaceuticals (India )Private Limited - Company Profile

It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2002.
2002 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Lok-Beta Pharmaceuticals (India )Private Limited

Lok-Beta Pharmaceuticals (India )Private Limited, a active private limited company, was established on 18 April 2002 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230MH2002PTC135577. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹3.07 M.

It upholds a compliant status. Its leadership includes Sudhanshu Kumar Singh (Director), Hina Kiran (Director), Alok Awadhesh Kumar (Managing Director). Past directors included Satyakam Kiran Kashyap, Rina Singh, Hina Kiran. It holds ₹37.30 Cr open charges and ₹9.31 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 324 Corporate Centre Nirmallifew Style Lbs Marg Mulund(W), Mumbai, Maharashtra, 400080.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230MH2002PTC135577

  • Registration Number

    135577

  • Incorporation Date

    18 April 2002

  • Authorized Capital

    ₹1.00 Cr

  • Paid-Up Capital

    ₹3.07 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 Cr
  • Paid Up Capital ₹ 3.07 M
  • Company Age 23 Year, 10 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 37.30 Cr
  • Satisfied Charges ₹ 9.31 Cr
  • Revenue Growth **** 87.01%
  • Profit Growth **** 16.92%
  • Ebitda **** 379.88%
  • Net Worth 4.02%
  • Total Assets **** 13.81%
Company report

Lok-Beta Pharmaceuticals (India )Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Lok-Beta Pharmaceuticals (India )Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Lok-Beta Pharmaceuticals (India )Private Limited?
Current Directors
Name Designation Appointment Date Status
Sudhanshu Kumar Singh Director 22 Aug 2012 Current
Hina Kiran Director 01 Oct 2014 Current
Alok Awadhesh Kumar Managing Director 18 Apr 2002 Current
Ashish Kumar Director 01 Dec 2022 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Whole-Time Director 30 Mar 2017 Past
Pramod Abcsdd Additional Director 12 Aug 2020 Past
Pramod Abcsdd Director 01 Apr 2022 Past
Pramod Abcsdd Director 24 Aug 2012 Past
Pramod Abcsdd Director 01 Mar 2017 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Lok-Beta Pharmaceuticals (India )Private.

Lok-Beta Pharmaceuticals (India )Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 87.01% increase. The company also saw a substantial improvement in profitability, with a 16.92% increase in profit. The company's net worth moved up by a moderate rise of 4.02%.

Lok-Beta Pharmaceuticals (India )Private revenue growth over time
Lok-Beta Pharmaceuticals (India )Private profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 87.01%
*******
*******
*******
*******
Revenue from Operations
*******
 104.08%
*******
*******
*******
*******
Total Assets
*******
 13.81%
*******
*******
*******
*******
Profit or Loss
*******
 16.92%
*******
*******
*******
*******
Net Worth
*******
 4.02%
*******
*******
*******
*******
EBITDA
*******
 379.88%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Lok-Beta Pharmaceuticals (India )Private?

In 2021, Lok-Beta Pharmaceuticals (India )Private had a promoter holding of 75.40% and a public holding of 24.60%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹372,960,000.00

Satisfied Charges

₹93,100,000.00

Charges Breakdown by Lending Institutions
  • Axis Bank Limited : 34.90 Cr
  • State Bank Of India : 2.40 Cr
Latest Charge Details
Date Lender Amount Status
25 May 2022 Axis Bank Limited ₹2.24 Cr Open
22 Apr 2022 Axis Bank Limited ₹2.15 Cr Open
26 Mar 2021 State Bank Of India ₹2.40 Cr Open
17 Feb 2021 Axis Bank Limited ₹10.00 Cr Open
08 Jan 2021 Axis Bank Limited ₹1.24 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Lok-Beta Pharmaceuticals (India )Private?

Unlock and access historical data on people associated with Lok-Beta Pharmaceuticals (India )Private, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Lok-Beta Pharmaceuticals (India )Private, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lok-Beta Pharmaceuticals (India )Private's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Lok-Beta Pharmaceuticals (India )Private
Recent Activity within the Organization
  • Annual General Meeting

    Lok-Beta Pharmaceuticals (India )Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Lok-Beta Pharmaceuticals (India )Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.

  • Director Appointment

    Ashish Kumar was appointed as a Director was appointed as a Director on 01 Dec 2022 & has been associated with this company since 3 years 3 months . was recorded as a recent event.

  • Charges

    Progress on A charge with Axis Bank Limited amounted to Rs. 2.24 Cr with Charge ID 100583548 was registered on 25 May 2022. was documented.

  • Charges

    The activity A charge with Axis Bank Limited of Rs. 2.15 Cr registered on 22 Apr 2022 with Charge ID 100582327 was modified on 25 May 2022. was completed.

  • Charges

    A charge with Axis Bank Limited amounted to Rs. 2.15 Cr with Charge ID 100582327 was registered on 22 Apr 2022. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Lok-Beta Pharmaceuticals (India )Private Limited?

The CIN of Lok-Beta Pharmaceuticals (India )Private Limited is U24230MH2002PTC135577.

Where is Lok-Beta Pharmaceuticals (India )Private Limited headquartered?

Lok-Beta Pharmaceuticals (India )Private Limited is headquartered at 324 Corporate Centre Nirmallifew Style Lbs Marg Mulund(W), Mumbai, Maharashtra, 400080.

When was Lok-Beta Pharmaceuticals (India )Private Limited incorporated?

Lok-Beta Pharmaceuticals (India )Private Limited was incorporated on 18 April 2002.

Who are the current directors of Lok-Beta Pharmaceuticals (India )Private Limited?

The current directors of Lok-Beta Pharmaceuticals (India )Private Limited are

What is the primary industry of Lok-Beta Pharmaceuticals (India )Private Limited?

The primary industry of Lok-Beta Pharmaceuticals (India )Private Limited is Manufacturing.

Is Lok-Beta Pharmaceuticals (India )Private Limited a listed company?

Lok-Beta Pharmaceuticals (India )Private Limited is unlisted.

What is the capital structure of Lok-Beta Pharmaceuticals (India )Private Limited?

The authorized capital of Lok-Beta Pharmaceuticals (India )Private Limited is ₹1.00 Cr, and the paid-up capital is ₹3.07 M.

What is the compliance status of Lok-Beta Pharmaceuticals (India )Private Limited?

The compliance status of Lok-Beta Pharmaceuticals (India )Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available